Pantothenate kinase—associated neurodegeneration (PKAN) is a progressive neurodegenerative disorder with autosomal recessive inheritance. The major symptoms of PKAN include the onset before the age of 20 years, progressive pyramidal and extrapyramidal signs, retinitis pigmentosa, optic atrophy, dementia, and iron depositions in the globus pallidus. The authors present 3 patients with proven molecular diagnosis of PKAN, in whom 2 novel mutations of PANK2 gene have been identified.
Battistella P., Midena E., Suppiej A., Carollo C.Optic atrophy as the first symptom in HSS . Child Nerv Syst.1998;14:135-138.
3.
Casteels I., Spileers W., Swinnen T., et al. Optic atrophy as the presenting sign in Hallervorden-Spatz-syndrome . Neuropediatrics. 1994;25:265-267.
4.
Hickman SJ, Ward NS, Surtees Rah, et al. How broad is the fenotype of Hallervorden Spatz disease. Acta Neurol Scand.2001;103:201-203.
5.
Oner O., Oner P., Deda G., Icagasioglu D.Psychotic disorder in a case with Hallervorden Spatz disease. Acta Psychiatr Scand.2003;108:394-398.
6.
Guimaraes J. , Santos JVGeneralized freezing in Hallervorden Spatz syndrome—case report. Eur J Neurol.1999;6:509-513.
7.
Zhou B., Westaway SK, Levinson B., et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet.2001;28:345-349.
8.
Coryell J., Gregory A., Hayflick SJPantothenate kinase-associated neurodegeneration. Available at: http://www.geneclinics.org/profiles/pkan/index.html. Accessed August 13, 2002.
9.
Hayflick SJ, Westaway SK, Levinson B., et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med.2003;348:33-40.
10.
Pellecchia MT, Valente EM, Cif L., et al. The diverse phenotype and genotype of pantothenate kinase associated neurodegeneration. Neurology . 2005;64:1810-1812.
11.
Baumeister FA, Auer DP, Hortnagel K., et al. The eye of the tiger sign is not a reliable disease marker for HSS. Neuropediatrics. 2005;36:221-222.
12.
Hartig MB, Hortnagel K., Garavaglia B., et al. Genotypis and fenotypic spectrum of PKAN 2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol.2006;59:248-256.
13.
Zolkipli Z. , Dahmoush H., Saunders DE, et al. Pantothenate kinase 2 mutation with classic pantothenate-kinase-associated neurodegeneration without eye of the tiger sign on MRI in a pair of siblings. Pediatr Radiol.2006;36:884-886.
14.
Gregory A., Hayflick SJNeurodegeneration with brain iron accumulation. Folia Neuropathol . 2005;43:286-296.
15.
Hortnagel K., Prokisch H., Meitinger T.An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria. Hum Mol Genet.2003;12(3):321-327.
16.
Johnson MA, Kuo YM, Westaway SK, et al. Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration . Ann N Y Acad Sci.2004;1012:282-298.
17.
Kotzbauer PT, Truax AC, Trojanowski JQ, Lee Vmy.Altered neuronal mitochondrial Coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability and catalytic activity of mutant pantothenate kinase 2. J Neurosci.2005;25(3):689-698.
18.
Kyriagis M., Gratta SP, Scheinberg A., et al. Status dystonicus and Hallervorden Spatz disease: treatment with intratecal baclofen and pallidotomy. J Paediatr Child Health. 2004;40:322-325.
Hortnagel K. , Prokisch H., Meitinger T.An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria. Hum Mol Genet.2003;12(3):321-327.
21.
Hermann W., Reuter M., Barthel H., et al. Diagnosis of Hallervorden-Spatz disease using MRI and 123I- Beta-CIT-SPECT and 123I-IBZM-SPECT. Eur Neurol.2000;43:187-188.
22.
Hoon AH, Reinardt EM, Kelley RI, et al. Brain magnetic resonance imaging in suspected extrapiramidal cerebral palsy: observations in distinguishing genetic-metabolic from acquired causesJ Pediatr.1997;113:240-245.
23.
Chakravarty A., Mukherjee A., Sen A.Familial pediatric rapidly progressive extrapyramidal syndrome: is it Hallervorden Spatz disease?Pediatr Neurol.2003;29:170-172.
24.
Simonati A. , Trevisan C., Salviati A., Rizzuto N.Neuroaxonal dystrophy with dystonia and pallidal involvement. Neuropediatrics. 1999;30:151-154.
25.
Hortnagel K. , Nardocci N., Zorzi G., et al. Infantile neuroaxonal dystrophy and pantothenate kinase associated neurodegeneration. Locus heterogeneity. Neurology. 2004;63:922-924.
26.
Houlden H., Lincoln S., Farrer M., et al. Compound heterozygotous PANK 2 mutations confirm HARP and HSS are allelic. Neurology. 2003;61:1423-1426.
27.
Ching Khl, Westaway SK, Gitschier J., et al. HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration. Neurology. 2002;58:1673-1674.
28.
Houlden H., Lincoln S., Farrer M., et al. Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic. Neurology. 2003;61:1423-1426.
